Cargando…
Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
Introduction: Cochlear implantation in patients with Ménière’s disease (MD) is the treatment of choice in cases of functional deafness. Additional vertigo control is of central importance in this group of patients. Endolymphatic hydrops (ELH) is the pathophysiological correlate of MD and can be eval...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296110/ https://www.ncbi.nlm.nih.gov/pubmed/37371333 http://dx.doi.org/10.3390/brainsci13060853 |
_version_ | 1785063580227338240 |
---|---|
author | Pfeiffer, Christoph J. Gehl, Hans-Björn Scholtz, Lars-Uwe Goon, Peter Sudhoff, Holger Todt, Ingo |
author_facet | Pfeiffer, Christoph J. Gehl, Hans-Björn Scholtz, Lars-Uwe Goon, Peter Sudhoff, Holger Todt, Ingo |
author_sort | Pfeiffer, Christoph J. |
collection | PubMed |
description | Introduction: Cochlear implantation in patients with Ménière’s disease (MD) is the treatment of choice in cases of functional deafness. Additional vertigo control is of central importance in this group of patients. Endolymphatic hydrops (ELH) is the pathophysiological correlate of MD and can be evaluated by magnet resonance imaging (MRI). Bilateral MD occurs in 10–33% and can be the reason for a postoperative persisting or newly occurring vertigo in this group. Recent developments in the field of implant magnets and experience in MRI sequences allow the diagnostic performance of MRI in cochlear implantees to be evaluated. The aim of the present study was to evaluate the possibility of MRI as a visual diagnostic tool for endolymphatic hydrops in cochlear implantees. Material and Methods: This was a retrospective study including three cochlear implantees (age: 61–76 years, one female, two male) suffering from MD who, postoperatively, had a recurrence of vertigo with Ménière’s-like symptoms. An MRI was performed for the evaluation of ELH (ELH-MRI). MRI observation was performed by a 4 h iv. delayed Gad 3 D Flair sequence. Results: In all cases, the ipsilateral implant magnet artifact covered the vestibulum, the semicircular canals and the cochlea. The contralateral vestibulum, the semicircular canal and the cochlea were fully observable, and a classification of the ELH-MRI could be performed. Conclusion: ELH-MRI scanning allows for the detection of contralateral labyrinthine endolymphatic hydrops and is a tool for the postoperative evaluation of vertigo in cochlear implantees. |
format | Online Article Text |
id | pubmed-10296110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102961102023-06-28 Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation Pfeiffer, Christoph J. Gehl, Hans-Björn Scholtz, Lars-Uwe Goon, Peter Sudhoff, Holger Todt, Ingo Brain Sci Communication Introduction: Cochlear implantation in patients with Ménière’s disease (MD) is the treatment of choice in cases of functional deafness. Additional vertigo control is of central importance in this group of patients. Endolymphatic hydrops (ELH) is the pathophysiological correlate of MD and can be evaluated by magnet resonance imaging (MRI). Bilateral MD occurs in 10–33% and can be the reason for a postoperative persisting or newly occurring vertigo in this group. Recent developments in the field of implant magnets and experience in MRI sequences allow the diagnostic performance of MRI in cochlear implantees to be evaluated. The aim of the present study was to evaluate the possibility of MRI as a visual diagnostic tool for endolymphatic hydrops in cochlear implantees. Material and Methods: This was a retrospective study including three cochlear implantees (age: 61–76 years, one female, two male) suffering from MD who, postoperatively, had a recurrence of vertigo with Ménière’s-like symptoms. An MRI was performed for the evaluation of ELH (ELH-MRI). MRI observation was performed by a 4 h iv. delayed Gad 3 D Flair sequence. Results: In all cases, the ipsilateral implant magnet artifact covered the vestibulum, the semicircular canals and the cochlea. The contralateral vestibulum, the semicircular canal and the cochlea were fully observable, and a classification of the ELH-MRI could be performed. Conclusion: ELH-MRI scanning allows for the detection of contralateral labyrinthine endolymphatic hydrops and is a tool for the postoperative evaluation of vertigo in cochlear implantees. MDPI 2023-05-25 /pmc/articles/PMC10296110/ /pubmed/37371333 http://dx.doi.org/10.3390/brainsci13060853 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Pfeiffer, Christoph J. Gehl, Hans-Björn Scholtz, Lars-Uwe Goon, Peter Sudhoff, Holger Todt, Ingo Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation |
title | Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation |
title_full | Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation |
title_fullStr | Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation |
title_full_unstemmed | Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation |
title_short | Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation |
title_sort | endolymphatic hydrops magnet resonance imaging in ménière’s disease patients after cochlea implantation |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296110/ https://www.ncbi.nlm.nih.gov/pubmed/37371333 http://dx.doi.org/10.3390/brainsci13060853 |
work_keys_str_mv | AT pfeifferchristophj endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation AT gehlhansbjorn endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation AT scholtzlarsuwe endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation AT goonpeter endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation AT sudhoffholger endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation AT todtingo endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation |